On Thursday, 6th August, the recent earnings result was posted by the biopharmaceutical company. For the quarter, the earnings per share (EPS) reported by the firm was ($0.42) matching with the consensus estimate of ($0.47) by $0.05. Syndax Pharmaceuticals (NASDAQ:SNDX) had a 91.09% negative return on equity and a 4,155.11% negative net margin. For the quarter, the company reported $0.38 million in revenue. As per the estimates of equity analysts, the company may announce -1.82 EPS for the current fiscal year.